DelMar Pharmaceuticals, Inc. 4
4 · DelMar Pharmaceuticals, Inc. · Filed Jun 28, 2017
Insider Transaction Report
Form 4
Mohr Erich
Director
Transactions
- Purchase
Common Stock
2017-06-26$3.60/sh+4,167$15,001→ 6,110 total
Footnotes (1)
- [F1]The Reporting Person purchased the shares in a private transaction for an aggregate purchase price of CDN $20,000. Reported price is based on exchange rate of 0.75.